...
首页> 外文期刊>Human reproduction update >Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: evidence for importance of the androgen-oestrogen balance and assessment of the relevance to man.
【24h】

Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: evidence for importance of the androgen-oestrogen balance and assessment of the relevance to man.

机译:新生儿暴露于强力和环境雌激素以及大鼠雄性生殖系统异常中:雄激素-雌激素平衡的重要性和与人的相关性评估的证据。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The effects on reproductive tract development in male rats, of neonatal exposure to potent (reference) oestrogens, diethylstilboestrol (DES) and ethinyl oestradiol (EE), with those of two environmental oestrogens, octylphenol and hisphenol A were systematically compared. Other treatments, such as administration of a gonadotrophin-releasing hormone antagonist (GnRHa) or the anti-oestrogen tamoxifen or the anti-androgen flutamide, were used to aid interpretation of the pathways involved. All treatments were administered in the neonatal period before onset of puberty. The cellular sites of expression of androgen receptors (AR) and of oestrogen receptor-alpha (ERalpha) and ERbeta were also established throughout development of the reproductive system. The main findings were as follows: (i) all cell types that express AR also express one or both ERs at all stages of development; (ii) Sertoli cell expression of ERbeta occurs considerably earlier in development than does expression of AR; (iii) most germ cells, including fetal gonocytes, express ERbeta but not AR; (iv) treatment with high, but not low, doses of potent oestrogens such as DES and EE, induces widespread structural and cellular abnormalities of the testis and reproductive tract before puberty; (v) the latter changes are associated with loss of immunoexpression of AR in all affected tissues and a reduction in Leydig cell volume per testis; (vi) none of the effects in (iv) and (v) can be duplicated by treating with high-dose octylphenol or bisphenol A; (vi) none of the reproductive tract changes in (iv) and (v) can be induced by simply suppressing androgen production (GnRHa treatment) or action (flutamide treatment); and (vii) the adverse changes induced by high-dose DES (iv and v) can be largely prevented by co-administration of testosterone. Thus, it is suggested that many of the adverse changes to the testis and reproductive tract induced by exposure to oestrogens result from a combination of high oestrogen and low androgen action. High oestrogen action or low androgen action on their own are unable to induce the same changes.
机译:系统地比较了新生儿暴露于强效(参考)雌激素,二乙基雌二醇(DES)和乙炔雌二醇(EE)对雄性大鼠生殖道发育的​​影响,以及两种环境雌激素辛基酚和组酚A的影响。其他治疗方法,如给予促性腺激素释放激素拮抗剂(GnRHa)或抗雌激素他莫昔芬或抗雄激素氟他胺等,也有助于解释所涉及的途径。所有治疗均在青春期开始之前的新生儿期进行。在整个生殖系统的发育过程中,还建立了雄激素受体(AR)以及雌激素受体α(ERalpha)和ERbeta的细胞表达位点。主要发现如下:(i)所有表达AR的细胞类型在发育的各个阶段也表达一个或两个ER。 (ii)ERbeta的支持细胞表达比AR的表达早得多; (iii)大多数生殖细胞,包括胎儿生殖细胞,表达ERbeta但不表达AR; (iv)用高剂量但不低剂量的有效雌激素(例如DES和EE)治疗,会在青春期之前引起睾丸和生殖道的广泛结构和细胞异常; (v)后一种变化与所有受影响组织中AR免疫表达的丧失和每个睾丸Leydig细胞体积的减少有关; (vi)用高剂量的辛基苯酚或双酚A处理不能复制(iv)和(v)中的任何作用; (vi)(iv)和(v)中的任何生殖道变化都不能通过简单地抑制雄激素产生(GnRHa处理)或作用(氟他胺处理)来诱导; (vii)并用睾丸激素可在很大程度上预防高剂量DES(iv和v)引起的不良变化。因此,建议由暴露于雌激素引起的对睾丸和生殖道的许多不利变化是由高雌激素作用和低雄激素作用的组合引起的。高雌激素作用或低雄激素作用本身无法诱导相同的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号